MIT technology makes a strong debut at the Ronkyla Chin Filler Injection New Product Launch Event

Jing Diamond Biomedical and Tai Zhong join forces to seize the NT$7 billion lipolysis market opportunity Jing Diamond Biomedical (hereinafter referred to as “Jing Diamond Biomedical”, stock code: 6815) held a launch event for the Ronkyla chin filler injection today (March 4th). General Manager Xie Jiaxian stated that Ronkyla is one of only two legally […]

MIT technology makes a strong debut at the Ronkyla Chin Filler Injection New Product Launch Event 繼續閱讀 »

晶鑽生醫2023營運展望

Diamond Biotechnology 2023 Business Outlook

Taipei, January 23, 2023 – Crystal Diamond Biomedical Co., Ltd. (referred to as “Crystal Diamond Biomedical,” stock code: 6815) held a corporate briefing today. General Manager, Xie Jia-Xian, announced that the company will accelerate its growth with six strategies and has an optimistic outlook for the next two years’ operations. Crystal Diamond Biomedical focuses on

Diamond Biotechnology 2023 Business Outlook 繼續閱讀 »